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Abstract
Background: Clinical Practice Guidelines (CPGs) available today are not extensively used due to
lack of proper integration into clinical settings, knowledge-related information resources, and lack
of decision support at the point of care in a particular clinical context.
Objective: The PRESGUID project (PREScription and GUIDelines) aims to improve the assistance
provided by guidelines. The project proposes an online service enabling physicians to consult
computerized CPGs linked to drug databases for easier integration into the healthcare process.
Methods: Computable CPGs are structured as decision trees and coded in XML format.
Recommendations related to drug classes are tagged with ATC codes. We use a mapping module
to enhance computerized guidelines coupling with a drug database, which contains detailed
information about each usable specific medication. In this way, therapeutic recommendations are
backed up with current and up-to-date information from the database.
Results: Two authoritative CPGs, originally diffused as static textual documents, have been
implemented to validate the computerization process and to illustrate the usefulness of the
resulting automated CPGs and their coupling with a drug database. We discuss the advantages of
this approach for practitioners and the implications for both guideline developers and drug
database providers. Other CPGs will be implemented and evaluated in real conditions by clinicians
working in different health institutions.
Background
CPGs integrate generic recommendations for specific
medical circumstances. They have been defined as "sys-
tematically developed statements to assist practitioner
and patient decisions about appropriate health care for
specific medical circumstances" [1]. They are designed to
compile the best medical knowledge in order to provide
physicians with a practical decisional aid. Clinical guide-
lines aim to eliminate clinician errors and promote best
medical practice.
Most CPGs are now easily accessible on specialized web
sites. For instance, the National Guideline Clearing-
house.[2] alone has almost 1,000 publicly accessible
guidelines. The ANAES (Agence Nationale d'Accréditation
et d'Evaluation en Santé: The agency tasked by the French
government with the production of medical references
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[3]. The wide diffusion of CPGs does not however solve
the problem of their effective use in daily practice.
Research on the lack of adherence to CPGs has not been
fully carried out. Davis' paper [4] shows that the compli-
ance with guidelines increases if it is developed with the
direct participation of clinician users (50% increase in rel-
ative compliance). Attaching guidelines to patients'
records is a second important factor (20 % increase).
The guidelines are usually issued as long sealed electronic
narratives (i.e.static PDF or HTML documents) that are
difficult to use at the point of care during time-limited
medical consultations. Disseminating CPGs in such a tex-
tual format has proved inefficient. The practitioner has to
read several pages in order to find the appropriate care rec-
ommendation for a specific clinical circumstance. Their
practical aspect rather than their content is at fault. Guide-
lines would prove much more efficient if they were avail-
able in the healthcare setting, integrated in the health care
information system, easily adaptable to given clinical sit-
uations/scenarios and able to avoid overloading physi-
cians with non-essential information. Minimizing the
time spent consulting CPGs is crucial when attempting to
improve their usage in every day practice. Physicians need
both timely and pragmatic information to provide
patients with the most appropriate care, and computer-
ized CPGs have proved valuable in this respect [5,6].
Many authors report integration in the information sys-
tem as a crucial point for the dissemination of CPGs. The
heterogeneity of legacy schemata and local vocabularies is
an important reason why software systems are not inter-
operable. The community effort to develop prescribing
aid systems coupled with computerized CPGs and requir-
ing Electronic Medical Records (EMRs) is considerable
[7,8]. CPG-EMR integrations are desirable  but not always
feasible, for the moment, when CPGs are to be extensively
disseminated [9,10]. EMRs are not always available and
the data they contain may not be complete or structured
well enough for computer interpretation. Few practition-
ers use EMRs able to manage structured and standardized
data in France today [11]. Their large number and their
heterogeneity are obstacles to their proper interoperability
(e.g., there are more than 120 medical practice software
packages currently available on the French market and
most of these include an EMR module). In other words
producing CPGs today which are integrated in the physi-
cian private information system is very expensive and the
results are not easily accessible.
However, more and more physicians are connected to the
Internet and use it to search for the available CPGs [12].
Internet becomes an efficient means to improve CPGs'
impact on daily practice if these online CPGs actually pro-
vide practitioners with pragmatic assistance [13]. Provid-
ing current and precise information on drugs prescription
within the CPGs will help improve both drug usage and
routine CPG compliance.
The PRESGUID project objectives
From a pragmatic point of view, very few French physi-
cians, in private practice, currently use an electronic
patient record at their place of work. Without discarding
the fully-integrated approach for the future, we have cho-
sen, in the PRESGUID project (PREScriptions and GUIDe-
lines), a pragmatic approach for the first step of
implementation. We assume that producing more precise
customized and shortened advice for drug prescription
than the textual formats generally used by health agencies,
significantly enhances CPG dissemination and health care
quality. The project aims to meet the information needs of
the practicing physician by combining clinical guidelines
with documentation of regularly updated scientific evi-
dence and reliable documentation on drug descriptions.
The CPGs produced by ANAES usually recommend the
most appropriate therapeutic drug classes given the clini-
cal setting. However this help is not sufficient in the daily
healthcare process. Physicians must also choose among
the recommended classes the appropriate specific medica-
tion to be prescribed. Ideally, clinicians should know
every drug available and keep up-to-date with current
pharmacopoeia (new molecules, market recalls, contrain-
dications, marketing authorizations, etc.). In addition,
they should make their selection based on both medical
and economical criteria (using different incentives, the
government encourages the prescription of cheaper
generic medications). Computerizing CPGs and coupling
them with drug databases for more complete information
and improved clinical adaptability represents a definite
improvement as far as physicians are concerned.
Vidal® is currently commercializing such a database which
is both authoritative and extensively used by French phy-
sicians (Vidal is equivalent to the PDR in the USA) [14].
The online version gives access to medication mono-
graphs and allows checking for drug interactions among a
list of drugs selected by the practitioner. Yet, it does not
include any module guiding the users towards CPGs or
definite medical references.
The PRESGUID project is designed as an online service
enabling physicians to consult computerized CPGs linked
with drug databases allowing a patient specific decision
support. It will consequently improve CPG consultation
and integration into the healthcare process. We use a prag-
matic approach both to implement the textual CPGs from
the ANAES into a computer-interpretable format and toPage 2 of 12
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Vidal® drug database.
The purpose is to provide physicians with an interactive
CPG consultation interface displaying recommendations
that match relevant patient data and the clinical setting.
PRESGUID provides a web-based guideline system that
takes, as input, clinical data on a particular patient and
returns, as output, the customized recommendation.
Should the recommendations require prescribing drugs,
the system will query the drug database and will display
detailed information about the relevant specific
medications.
Methods
The guideline task asks for data requirements, abstraction
(patient characteristics, classes of medications) and mod-
eling requirements. Computable CPG development is
facilitated by the use of an architecture integrating modu-
lar components and including user-friendly authoring
tools and execution facilities [15]. The PRESGUID project
is based on such a Web architecture including a CPG
development and distribution platform as well as a drug
database.
The platform includes various tools required for the devel-
opment and distribution of computerized CPGs. This
platform was further described in a previous paper [16].
Figure 1 presents the architecture of the platform and its
main features are presented below.
CPG model and graphic editor
Representing CPGs in a computer-interpretable format is
a critical issue for guideline development, implementa-
tion, and evaluation. Our knowledge representation
model (Figure 2) is inspired by the GLIF model [17]: a
CPG is a sequence of decision and action steps.
Action steps are used in order to collect patient data, com-
pute and assign data value (e.g., compute the body mass
index from weight and height) and display messages or
recommendations.
Decision steps enable evaluation of a condition com-
posed of one or more criteria. These criteria concern the
data values derived from effecting the previous action
steps. We use classical comparative operators, logical
operators and mathematical functions to produce the
expressions to be evaluated.
Patient data inferred while performing a CPG are repre-
sented by DataItem class (Figure 3). The DataItem class is
composed of one or more attribute-value pairs. The value
type is either numeric or string. Values are constrained by
a range (minimum, maximum) or a domain of values
defined in a given list of items.
Architecture of the PRESGUID projectFigur  1
Architecture of the PRESGUID project.Page 3 of 12
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various options to create DataItem instances according to
their own needs for a computable CPG. At this stage, we
do not want to impose a particular patient data classifica-
tion because there is no standard clearly established and
widely used for patient data representation and classifica-
tion. However, use of standard classification is a key point
to allow interoperability and coupling CPGs with EMRs.
In order take this into account, DataItem and Attribute
instances are identified by an "Id" attribute. Future imple-
mentation may use this "Id" in order to map patient data
inferred in a guideline with targeted classifications (e.g.
ICD-10, MeSH,...).
Further, we have elaborated a visual guideline-authoring
tool which provides a graphical interface to create and
maintain guideline logic and content (Figure 4). Our edi-
tor expresses the content of a CPG structured as an algo-
rithm in XML format. The syntax we use within XML CPG
documents is specific to our CPG engine. Classes of our
model are instantiated as XML tags containing sub-ele-
ments and attributes which detail the CPG logical struc-
ture and its content.
CPG model – Main classes and their main attributes (UML formalism)Figure 2
CPG model – Main classes and their main attributes (UML formalism).Page 4 of 12
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authors easily create accurate CPGs. A major considera-
tion was to ensure flexibility and comprehensiveness for
the authors. Within the authoring tool, a CPG is presented
as a decision tree handled with drag and drop operations.
The tool also provides specific forms to structure each ele-
ment of the guideline (steps, decision criteria, patient data
which have to be inferred, recommendations, etc.). Clini-
cian experts involved in developing computable CPGs are
familiar with decision tree presentation often used to
draw-up classical paper-based guidelines. It is therefore
easier for them to take part in the authoring process.
Within the authoring tool, patient data and other ele-
ments of the CPG can be linked to didactic documents
(bibliographic references, definition of medical concepts,
additional multimedia documents, relevant web sites
URLs...) which can be displayed while consulting the
CPG. During the authoring process, the CPG as well as its
linked documents are identified by a set of properties
(authors, summary, usage, MeSH keywords...) and are
indexed on the CPG server. Moreover, guideline recom-
mendations are ranked by evidence grading as defined by
the Oxford Center for EBM.)[18].
CPG server and engine
Fully developed CPGs are stored and indexed on a web
server. To improve accuracy and consistency of guidelines
we have opted for a procedure in which the guidelines can
be tested in real conditions before putting them at users'
disposal. An 'approved' status is delivered by the specialist
in charge of the tests once he has judged the results satis-
factory: the CPG then becomes available for any clinicians
who have access to the server.
The guideline engine carries out a CPG according to
patient data values. It links the steps, infers the condi-
tional criteria and initializes actions to be performed
(patient data requests, data calculation, recommendation
display...).
The user interface is a dynamically generated web page.
Initially, the information presented in the user interface is
in XML format. We use eXtensible StyLe sheets (XSL) to
Patient data model – Classes and their main attributes (UML formalism)Figure 3
Patient data model – Classes and their main attributes (UML formalism) Example: Blood Pressure can be represented by a 
DataItem class instance with the following attributes: Systolic Pressure (SP), Diastolic Pressure (DP) and Patient Position during 
measurement (PatPos). SP and DP of «NumValue» type vary between 20 and 300. PatPos of «StringValue» type can be valued 
in 'standing' or 'lying' position.Page 5 of 12
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data entry forms and controls.
Drugs database
The Vidal® database provides information about those
drugs that are available on the French market and it is
accepted as a reference by all healthcare professionals. It is
implemented in an Oracle® relational database and deliv-
ered with a set of APIs providing access to detailed drug-
related data and documents (monographs, dosage, chem-
ical composition, etc.). The Vidal® database uses both the
ATC (Anatomic Therapeutic Classification) as well as its
own classification which although not formally recog-
nized is nevertheless extensively used by healthcare pro-
fessionals throughout France.
CPG and drugs database coupling
Knowledge coupling between CPGs and the drug database
is based on XML message exchanges. We have developed
a software component matching the XML description of
therapeutic classes recommended in CPGs with appropri-
ate medications within the Vidal® database.
To describe a drug prescription within a CPG we use an
XML tag (DRUG_PRESCRIPTION) containing the recom-
mended therapeutic class codes (either ATC or Vidal® clas-
sifications can be used). Since CPGs are expressed in XML
format, the original XML DRUG_PRESCRIPTION tag is
nested within a second tag standing for a message recom-
mending a drug-related therapy (Figure 5).
Guideline and 'Display Recommendation' step editionFigure 4
Guideline and 'Display Recommendation' step edition.Page 6 of 12
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browsing drug classifications; selecting required classes;
and finally automatic embedding of the
DRUG_PRESCRIPTION tags within recommendation
messages.
In addition, we have developed a drug-database access
component (DDBAC) designed to query the Vidal® data-
base whenever a DRUG_PRESCRIPTION tag is included
within a recommendation. This component uses Vidal®
APIs to find the medications which belong to specified
therapeutic classes. It produces and delivers an XML root
tag including the appropriate medications, for each of
which are specified: identifier, trade name, status (generic
/ referent), URL of the web page including the full mono-
graph and the therapeutic sub-classes if any (Figure 6).
The results are included within the initial CPG XML doc-
ument. Users may consult the different medications and
select the one to prescribe by consulting the detailed mon-
ographs from the drug database. Typical uses of the PRES-
GUID CPGs are described in the next section.
Results
We have computerized CPGs from the ANAES library.
Two textual CPGs issued by the ANAES (hypertension
management and diabetes mellitus treatment) have been
coded and implemented to test and validate the compu-
terization process (a demonstration version is available at
http://cybertim.timone.univ-mrs.fr/presguid/). These
CPGs have been computerised using our guideline-
authoring tool by the conceiver of this tool. Furthermore,
two GPs, not directly involved in the PRESGUID project,
have used the authoring tool in order to propose a com-
puterised version of five CPGs from ANAES (high blood
pressure, diabetes mellitus, cerebrovascular accident,
benign prostatic hypertrophy and cancer pain treatment).
They have been trained in the use of this tool over four
hours and they have help assistance if needed. Their work
is not yet fully completed. But so far, it appears that the
tool is user-friendly because it is mainly focused on struc-
turing a decision tree with especially intuitive drag-and-
drop operations. Only a dozen minutes or so is required
to get an initial version of a functional algorithm. It can be
executed immediately and improved easily step by step.
When initial textual CPGs are ambiguous and/or incom-
plete, it of course takes more time and expert advice is
A DRUG_PRESCRIPTION tag nested in a recommendation messageFigure 5
A DRUG_PRESCRIPTION tag nested in a recommendation message.Page 7 of 12
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that smokers have higher cardiovascular risk (the recom-
mendation is risk dependent) but does not specify which
patients must be considered as smokers (Current smok-
ers? Former smokers? Passive smokers? Active smokers?
Tobacco quantity?...). Similarly, it gives a recommenda-
tion for patients with renal dysfunction and another one
for patients with cardiac dysfunction but no explicit
advice about patients who have both diseases.
We realise that the initial CPGs should be improved dra-
matically. From this point of view, the guideline-editor
tool does not solve the problems of ambiguities and
incompleteness of the given guidelines but it highlights
these crucial problems. It helps towards validating guide-
lines given by experts.
A typical consultation scenario involving the diabetes
mellitus CPG is presented below.
During CPG consultation clinicians have to fill in patient
data forms dynamically generated by the CPG engine. The
collected data are summarized on the left hand side of the
screen (Figure 7). Once the data have been collected and
inferred, the system displays the recommendation
adapted to the patient's profile. Clinicians can simulate
data modifications and observe the effects on the
recommendations.
A DRUG_PRESCRIPTION tag nested in a recommenda-
tion is presented as a hyperlink (Figure 7, right-hand
side). It provides access to all the specific medications that
can be used in the present context.
Physicians may then browse medications (displayed in a
tree structure) and consult up-to-date monographs from
the Vidal® database (Figure 8).
Discussion
Key points to improve CPG effectiveness concern effi-
ciency, usefulness, information content, user-friendly
interface and CPG integration into the clinician workflow
processes prior to delivering recommendations on time,
at the point of care. Moreover, access to up-to-date
information and guided processes also improve drug
prescription safety [19]. In order to achieve these goals, we
propose computable and interactive CPGs that can be
used on computers connected to our server. The
A RESULT tag produce by the DDBACFigure 6
A RESULT tag produce by the DDBAC.Page 8 of 12
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data collected by clinicians during medical consultations.
Furthermore, recommendations regarding prescription
drugs are coupled with a knowledge database widely used
by clinicians. Within CPG consultation interface, practi-
tioners have direct access to detailed information which
will help them choose among the medications potentially
appropriate for the clinical context.
We have paid special attention to the accessibility and the
detail level of CPGs. CPG impact depends on the assump-
tion that clinicians will access the CPGs and will apply
them in patient-specific circumstances. They must be easy
to consult, integrated in the care process, and able to pro-
duce patient-specific recommendations rapidly.
The computerization of CPGs needs a strict and detailed
structuring of their contents. The variability of CPG types
and their complexity sometimes lead developers to con-
struct over-specific systems thus narrowing their field of
application. The authoring and the maintenance of guide-
line is a difficult process, which involves a detailed review
of all the alternatives by evaluating current scientific evi-
dence, a consensus process among medical experts, a spec-
ification of optimal decision and finally a documentation
of the recommendations. CPGs are often complex and
A diabetes mellitus therapy recommendation with evidence level given as a hyperlink «grade»Figur  7
A diabetes mellitus therapy recommendation with evidence level given as a hyperlink «grade». The recommendation is dis-
played on the right hand side of the screen. The link with the drug data base is activated by clicking on the drugs family recom-
mended (in this example, "sulfamides and alpha glucosidase inhibitors". On the left hand side, the data collected from the 
patient.Page 9 of 12
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form.
In PRESGUID the guideline editor is an easy to use
authoring interface requiring minimal training. It facili-
tates local adaptation and editing of guidelines. It can be
used to create any type of CPG structured as an algorithm.
It provides physicians with a very simple CPG manage-
ment tool.
The prescribing aid systems currently available help detect
drug contraindications and/or interactions. In our
approach to knowledge coupling with CPGs, we have
attempted to enhance both practical and operational
aspects. This approach goes along with other significant
efforts made to take the whole treatment strategy into
account within systems using both CPGs and drug-knowl-
edge databases: PRODIGY [7] and ASTI [8] are known
examples of these systems. CPG consultation in PRES-
GUID is similar to the "guided mode" and "interacting
mode" respectively of the ASTI and PRODIGY systems. In
both these systems, the CPG module is intended to be
provided as a plug-in/extension of commercial EMRs (one
specific EMR for ASTI, several EMRs for PRODIGY which
have to be compliant with minimum standards edited by
the National Health Service Information Authority of the
United Kingdom). Such an approach has great benefits in
improving CPG integration within clinical practice but
narrows their usage for the GPs who have these specific
EMRs. In France there are presently no edited standards
with which EMR software providers are supposed to be
compliant. Moreover, there are many EMR editing
software companies sharing this market. As a conse-
quence, developing computerised CPGs is still restricted
to very few systems and de facto few GPs have experience
in the use of computerised CPGs connected to their EMR
in France. This evidence convinces us that we have first to
find a way to providing access to computerised CPGs
potentially accessible to a large number of GPs without
the needs of specific systems. We are aware that it is a first
step to improving CPG use, but we also believe that it is a
necessary step to show to a large number of practitioners
and medical software providers the potentialities of com-
puterised CPGs. In our opinion, it is also a way to influ-
ence the authoritative textual CPGs developers:
computerising a CPG formatted as a textual document
Recommended specialities (left hand side) and monographic information (right hand side)Figure 8
Recommended specialities (left hand side) and monographic information (right hand side). Generic specialities appear in green, 
referring ones in red, others in blue.Page 10 of 12
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consequently improve its logical structure. This can be
illustrated for example, by the fact that in the French ASTI
project the hypertension management CPG from the
Canadian Medical Association has been preferred to the
French CPG from ANAES because the latter was less
detailed and less complete. Thus, computerisation of
CPGs is not just a solution to improve their use by practi-
tioners, it is also, as a first step, a quality assessment pro-
cedure to test the guidelines, and ideally to improve their
contents.
With the PRESGUID project, we designed a decision sys-
tem based on patient data directly collected from clinical
users that allows for easy switching between the CPGs and
the clinical system (this is a key requirement as far as
patient-specific decision support is concerned). This sys-
tem can be used as a stand-alone CPG system whose main
advantage is that it is ready for use whatever the structure
of the health information system may be. The associated
CPGs can be widely disseminated over the Internet and
easily shared between care providers. Further, this system
is interactive and physicians can easily modify patient
data to observe the effects on the resulting recommenda-
tions. We believe that this feature reduces the 'black box'
negative effect that some physicians may feel when using
decision-aid systems. This feeling is one of the obstacles to
the wider adoption of computerized CPGs [20]. Data col-
lection, presently assumed by the clinician user when he/
she consults the guideline, could be completed or
replaced by the use of a mapping module with an EMR.
Linking CPGs and EMR can improve their daily use. How-
ever, standalone CPGs can also have positive results in
helping clinicians to choose and memorise the appropri-
ate medication for a given patient [21].
As showed by Wang et al. [22] sharing CPGs among insti-
tutions can be achieved by using a mapping process
between a guideline model and generalized guideline exe-
cution tasks. Such evidence reinforces our conviction of
the necessity of basing computable CPG developments on
consensual models.
Our developments take advantage of the GLIF model that
presents many similarities with most models currently in
use [23]. As we have mentioned above, we use our own
syntax to format CPG with XML. We believe that this
syntax could be enriched and modified using XSL trans-
formations in order to be compliant with GLIF expression
language if needed. However, such transformations have
not been tested. Other researchers have also used this
emerging model as well as the XML format in order to
structure CPGs [24-26]. Suggestions were made to
improve CPG modeling based on patient data representa-
tion [27,28], logic specification [29,30] and additional
information [31]. Nonetheless, taking drug prescription
into account is also an important factor in improving CPG
modeling and implementing. This research has potential
implications both for CPG developers and providers of
electronic drug databases. Defining consensual methods
to match drug databases and computable CPGs will
enhance the whole treatment strategy. We suggest using a
'drug prescription' element embedding the ATC code
associated with recommended therapies. Classifications
may be different according to the drug databases that are
being targeted. However it is still preferable to use nation-
ally or internationally recognized classifications facilitat-
ing CPG sharing and re-use.
On the whole, we must bear in mind that CPG shareabil-
ity is not only a question of syntax used, of knowledge
representation and of coupling functionalities with EMRs.
CPG shareability also requires integration into the health
care workflow and similar/uniform health care processes.
We need further analyzes to find a model which can take
into account all these aspects so as to be fully satisfactory
when implemented in the real world.
PRESGUID is a decision support system based both on
authoritative CPGs and on an authoritative drug database.
The project also has potential implications for healthcare
institutions because the Vidal® database is now available
free of charge for institutions. Our developments are thus
applicable to the information systems used in these insti-
tutions. The coupling with other online drug databases
using ATC coding would be similar. To improve accessi-
bility, the guideline server uses a standard vocabulary
(MeSH) and a set of properties to reference the guidelines
(subjects, authors, public concerned, date, etc.). Thanks to
these properties, we can structure a catalogue of the avail-
able guidelines. Depending on his/her needs, each user
can build his/her own CPG list. In order to offer an even
better structured guideline catalogue we plan to use more
properties according to Shiffman et al. [31].
An evaluation study is currently in progress. Evaluations
of the user-interface of the PRESGUID system have
already been carried out by independent evaluators who
performed a standard usability inspection (heuristic eval-
uation). The recommendations from the usability study
revealed some problems. These recommendations have
already been taken into account in the re-engineering of
the Human-Computer Interface. The current online dem-
onstration version integrates these recommendations and
reflects corrections in line with the criterions of Scapin
and Bastien [32]. Evaluation of PRESGUID by GPs is
already planned. This evaluation will be performed using
five CPGs issued by the ANAES. The study protocol planes
to evaluate the use of the system by interviews and video-
recordings of GPs using the system.Page 11 of 12
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by taking advantage of the existing functionality that
checks for drug interactions. The next PRESGUID version
will use the API modules provided in the Vidal® database
to check for interactions between drugs recommended in
the CPGs and those already administered to patients.
Finally, we propose a method to disseminate the CPGs
produced by the ANAES in a user-friendly format and sub-
sequently improve their application in daily practice.
Experience shows that computerisation has to be taken
into account from the first stage of CPG development to
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